Company intelligence / Profile preview

Ruibeixin Pharmaceutical

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Ruibeixin Pharmaceutical is a Chinese biotechnology company dedicated to the development of innovative RNA interference (RNAi) therapeutics. Based in Beijing, the company employs a proprietary platform for siRNA sequence optimization and delivery technology, featuring both lipid nanoparticle (LNP) and GalNAc conjugation systems. Its pipeline is strategically focused on liver-targeted therapies for prevalent conditions such as chronic hepatitis B and metabolic disorders like hyperlipidemia. Ruibeixin's lead candidates, including RBX-202 and RBX-101, are currently progressing through pre-clinical development. The company aims to establish itself as a leader in the field of genetic medicine by enhancing the precision and safety of nucleic acid delivery.

Therapeutic areas: CardiovascularInfectious DiseasesMetabolic Disorders
Modalities: Small interfering RNALipid nanoparticle delivery therapyRNA therapy
Industry: Biotech

Beyond the preview

Go deeper on Ruibeixin Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ruibeixin Pharmaceutical.

Explore the full profile